Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 4Unknown 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Breast 1

Conditions

Urinary Bladder Neoplasms 10Carcinoma, Transitional Cell 7Ureteral Neoplasms 4Neoplasm Metastasis 4Breast Neoplasms 4Neoplasms 3Urethral Neoplasms 2Recurrence 2Urologic Neoplasms 1Urogenital Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Squamous Cell Carcinoma of Head and Neck 1Renal Insufficiency 1Prostatic Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Lung Neoplasms 1Locally Advanced or Metastatic Unresectable Urothelial Cancer 1Kidney Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × vinflunine × Clear all
NCT01091168 2019-09-16

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

Pierre Fabre Medicament

Phase 3 Completed
594 enrolled 11 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01529411 2019-04-04

MAJA

Spanish Oncology Genito-Urinary Group

Phase 2 Completed
86 enrolled
Genitourinary

Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, Neoplasms

NCT01599013 2015-12-08

JASINT1

Pierre Fabre Medicament

Phase 2 Completed
69 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis, Urogenital Neoplasms, Urologic Neoplasms, Renal Insufficiency

NCT00389155 2015-12-07

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Bristol-Myers Squibb

Phase 2/3 Completed
34 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡